Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06368193 · ClinicalTrials.gov registry record · NA

The Neuralert Stroke Monitor Pilot Trial

A NA study of Stroke and Surgery, sponsored by Neuralert Technologies.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06368193 is a NA study of Stroke and Surgery that is actively recruiting participants, run by Neuralert Technologies. The registered enrollment target is 50 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06368193, a NA study of Stroke and Surgery, is actively recruiting participants, sponsored by Neuralert Technologies.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This trial aims to demonstrate that the Neuralert Monitoring System will detect strokes before they would be identified by current standard of care. Each patient will be monitored for up to five days, depending on device connectivity or battery duration. Each monitoring session will consist of wearing a Neuralert device on each arm. For this pilot trial, we are interested in learning about Wi-Fi connectivity, successful data transmission, integration into clinical workflow, usability and tolerability.

Conditions Studied

Interventions

  • DEVICE Neuralert Monitor

Study Locations (1)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-12-12
Est. Completion 2027-05-01
Phase NA

Sponsor

Neuralert Technologies

2 total trials

What the Registry Record Tells You About NCT06368193

The ClinicalTrials.gov registry entry for NCT06368193 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Neuralert Technologies, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Neuralert Monitor is the first listed.

NCT06368193 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06368193 about?

NCT06368193 is a clinical study titled "The Neuralert Stroke Monitor Pilot Trial". This trial aims to demonstrate that the Neuralert Monitoring System will detect strokes before they would be identified by current standard of care. Each patient will be monitored for up to five days, depending on device connectivity or battery duration. Each monitoring session will consist of weari...

What is the current status of trial NCT06368193?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-12-12. Estimated completion is 2027-05-01.

What conditions does trial NCT06368193 study?

This clinical trial studies the following conditions: Stroke, Surgery.

What interventions are being tested in trial NCT06368193?

The interventions under investigation include: Neuralert Monitor (DEVICE).

Who is sponsoring clinical trial NCT06368193?

This trial is sponsored by Neuralert Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06368193 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.